India's Contract Research, Development, and Manufacturing Organization (CRDMO) industry is on a strong growth trajectory, with its market size expected to double from the current approx. USD 7 billion to approx. USD 14 billion by 2028, according to a report by Macquarie Equity Research.
Some Indian CDMOs have witnessed a 50 per cent year-on-year increase in Requests for Proposals (RFPs) in 2024, as global pharmaceutical companies look to diversify supply chains beyond China. Indian pharma services are priced 20 per cent lower than their Chinese counterparts, making them a c
Union Minister of State for Health and Family Welfare, Anupriya Patel, delivered the keynote address at the 15th International Meeting of World Pharmacopoeias (IMWP), hosted by the Indian Pharmacopoeia Commission (IPC) under the Ministry of Health and Family Welfare, Government of India, in
New Delhi [India], February 3: The highly anticipated 3rd edition of Pharma Live Expo & Summit 2025, a premier event for the global pharmaceutical, healthcare, and MedTech sectors, will be held from 17th to 19th April 2025 at the Bombay Exhibition Centre, Mumbai. Organized by ICEXPO Co
The report highlights that the "China+1" strategy, which involves companies diversifying operations beyond China, has opened doors for other Asian countries, including India. This shift is driving investments into India's pharma sector, enabling it to expand beyond its traditional focus on g
Ahmedabad (Gujarat) [India], December 9: AfterFirst Media (www.afterfirst.com) is a Digital Marketing Agency that primarily serves Pharma, Chemical and B2B Manufacturing companies, serving marquee clients like Shamrock Pharmachemi, Emil Pharmaceutical Industries, Rampex Labs, Belami Fine Che
Mumbai (Maharashtra) [India], December 6: Global pharma major Lupin Limited (Lupin) today announced that its R&D facility at Lupin Research Park, Pune has been awarded the LEED Platinum Certification for Operations and Maintenance by the U.S. Green Building Council (USGBC), the global le
India is not just cementing its position as a global innovation hub but is also an economic bright spot amid global uncertainties. Anil Matai, Director General of OPPI, said, "India's robust pharma ecosystem, bolstered by visionary government initiatives, positions the nation as a global
Speaking at the inauguration of the three-day International Pharma and Healthcare Exhibition (IPHEX 2024) organized by the Pharma Export Promotion Council of India (CAPEXIL) and the Ministry of Commerce and Industry in Greater Noida, Uttar Pradesh, Prasada called on the Indian pharmaceuti
Mumbai (Maharashtra) [India], August 12: Atul Bioscience Ltd (ABL), a 100 per cent subsidiary company of Atul Ltd, received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its manufacturing facility situated in Ambernath, Maharashtra.
Mumbai (Maharashtra) [India], July 16: The Startup Incubation and Innovation Centre (SIIC), the technology business incubator of the Indian Institute of Technology Kanpur (IITK), has entered into an agreement with Boehringer Ingelheim India, a leading global pharmaceutical company. The Boehr
The 9th edition of the Global Pharmaceutical Quality Summit which brought together experts, industry leaders, and stakeholders among others to foster knowledge exchange and deliberate on areas of importance in shaping the pharmaceutical landscape in India took place here on Thursday.